- Report
- November 2025
- 95 Pages
North America
From €3084EUR$3,450USD£2,645GBP
- Report
- November 2022
- 100 Pages
Global
From €5318EUR$5,950USD£4,561GBP
- Report
- July 2025
- 80 Pages
United States
From €5318EUR$5,950USD£4,561GBP
- Report
- August 2025
- 180 Pages
Global
From €4022EUR$4,500USD£3,449GBP
- Report
- August 2025
- 185 Pages
Global
From €4022EUR$4,500USD£3,449GBP
- Report
- June 2025
- 189 Pages
Global
From €4022EUR$4,500USD£3,449GBP
- Report
- January 2025
- 180 Pages
Global
From €4022EUR$4,500USD£3,449GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3352EUR$3,750USD£2,875GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1341EUR$1,500USD£1,150GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1117EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1117EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1117EUR$1,250USD£958GBP
- Report
- April 2023
- 115 Pages
Global
From €4246EUR$4,750USD£3,641GBP
- Report
- July 2025
- 350 Pages
Global
From €4424EUR$4,949USD£3,794GBP
- Report
- May 2024
- 131 Pages
Global
From €2681EUR$2,999USD£2,299GBP
€3574EUR$3,999USD£3,065GBP
- Report
- May 2024
- 133 Pages
Global
From €2681EUR$2,999USD£2,299GBP
€3574EUR$3,999USD£3,065GBP
- Report
- May 2024
- 129 Pages
Global
From €2681EUR$2,999USD£2,299GBP
€3574EUR$3,999USD£3,065GBP
- Report
- June 2025
- 269 Pages
Global
From €4465EUR$4,995USD£3,829GBP
- Report
- February 2023
- 79 Pages
Middle East, Africa
From €1341EUR$1,500USD£1,150GBP
- Report
- November 2022
- 226 Pages
Global
From €3218EUR$3,600USD£2,760GBP

Fluconazole is an antifungal drug used to treat a variety of fungal infections, including those caused by Candida species. It is commonly used to treat yeast infections, such as vaginal candidiasis, oropharyngeal candidiasis, and esophageal candidiasis. It is also used to treat cryptococcal meningitis, a fungal infection of the brain and spinal cord. Fluconazole is a member of the azole class of antifungal drugs, which work by inhibiting the synthesis of ergosterol, a component of fungal cell membranes.
Fluconazole is a widely used antifungal drug in the infectious diseases drugs market. It is used to treat a variety of fungal infections, including those caused by Candida species. It is available in both oral and intravenous formulations, and is often used in combination with other antifungal drugs.
Some companies in the Fluconazole market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more